Log In
Print
BCIQ
Print
Print this Print this
 

Mesupron (WX-671)

  Manage Alerts
Collapse Summary General Information
Company Wilex AG
DescriptionSecond-generation serine protease inhibitor targeting urokinase-type plasminogen activator (uPA)
Molecular Target Urokinase-type plasminogen activator (PLAU) (uPA) ; Serine protease
Mechanism of ActionSerine protease inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today